Literature DB >> 20177023

Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Jens Hillengass1, Kerstin Fechtner, Marc-André Weber, Tobias Bäuerle, Sofia Ayyaz, Christiane Heiss, Thomas Hielscher, Thomas M Moehler, Gerlinde Egerer, Kai Neben, Anthony D Ho, Hans-Ulrich Kauczor, Stefan Delorme, Hartmut Goldschmidt.   

Abstract

PURPOSE: With whole-body magnetic resonance imaging (wb-MRI), almost the whole bone marrow compartment can be examined in patients with monoclonal plasma cell disease. Focal lesions (FLs) detected by spinal MRI have been of prognostic significance in symptomatic multiple myeloma (sMM). In this study, we investigated the prognostic significance of FLs in wb-MRI in patients with asymptomatic multiple myeloma (aMM). PATIENTS AND METHODS: Wb-MRI was performed in 149 patients with aMM. The prognostic significance of the presence and absence, as well as the number, of FLs for progression into sMM was analyzed.
RESULTS: FLs were present in 28% of patients. The presence per se of FLs and a number of greater than one FL were the strongest adverse prognostic factors for progression into sMM (P < .001) in multivariate analysis. A diffuse infiltration pattern in MRI, a monoclonal protein of 40 g/L or greater, and a plasma cell infiltration in bone marrow of 20% or greater were other adverse prognostic factors for progression-free survival in univariate analysis.
CONCLUSION: We recommend use of wb-MRI for risk stratification of patients with asymptomatic multiple myeloma.

Entities:  

Mesh:

Year:  2010        PMID: 20177023     DOI: 10.1200/JCO.2009.25.5356

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  98 in total

Review 1.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

2.  Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma.

Authors:  Kosei Matsue; Hiroki Kobayashi; Yuya Matsue; Yoshiaki Abe; Kentaro Narita; Akihiro Kitadate; Masami Takeuchi
Journal:  Blood Adv       Date:  2018-05-08

3.  Haematological cancer: Treatment of smoldering multiple myeloma.

Authors:  S Vincent Rajkumar; Robert A Kyle
Journal:  Nat Rev Clin Oncol       Date:  2013-09-03       Impact factor: 66.675

4.  Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance.

Authors:  J Hillengass; M-A Weber; K Kilk; K Listl; B Wagner-Gund; M Hillengass; T Hielscher; A Farid; K Neben; S Delorme; O Landgren; H Goldschmidt
Journal:  Leukemia       Date:  2013-08-20       Impact factor: 11.528

Review 5.  Imaging in myeloma with focus on advanced imaging techniques.

Authors:  Tara Barwick; Laure Bretsztajn; Kathryn Wallitt; Dimitri Amiras; Andrea Rockall; Christina Messiou
Journal:  Br J Radiol       Date:  2019-01-03       Impact factor: 3.039

Review 6.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 7.  Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors:  Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

8.  Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.

Authors:  James E McDonald; Marcus M Kessler; Michael W Gardner; Amy F Buros; James A Ntambi; Sarah Waheed; Frits van Rhee; Maurizio Zangari; Christoph J Heuck; Nathan Petty; Carolina Schinke; Sharmilan Thanendrarajan; Alan Mitchell; Antje Hoering; Bart Barlogie; Gareth J Morgan; Faith E Davies
Journal:  Clin Cancer Res       Date:  2016-10-03       Impact factor: 12.531

Review 9.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Authors:  Amit Agarwal; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2012-12-05       Impact factor: 12.531

10.  [Focal lesions in whole-body MRI in multiple myeloma : Quantification of tumor mass and correlation with disease-related parameters and prognosis].

Authors:  S C Brandelik; J Krzykalla; T Hielscher; J Hillengass; J K Kloth; H U Kauczor; M A Weber
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.